Physician profile
Bidhya Timilsina
NPI 1083061022
$6,594.55
in general payments reported to CMS, 2019-2025
13 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $227 · 2021: $408 · 2022: $4,546 · 2023: $1,182 · 2024: $48.09 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,097 · Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,096.65 |
| Food and Beverage | $317.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,035.51 | 2020-2023 | Ensite Precision |
| Shockwave Medical, INC | $116.58 | 2020-2021 | |
| Scpharmaceuticals INC. | $110.31 | 2025 | |
| Pfizer INC. | $55.32 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.47 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $39.63 | 2023-2024 | |
| Medtronic, INC. | $37.05 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $35.08 | 2023 | Eliquis, Camzyos |
| Siemens Medical Solutions USA, INC. | $34.92 | 2025 | Acuson Freestyle Diagnostic Ultrasound System |
| Bard Peripheral Vascular, INC. | $25.34 | 2023 | Lutonix Drug Coated Balloon |
| Medtronic Vascular, INC. | $18.50 | 2020 | |
| Ge Healthcare | $17.29 | 2021 | |
| Teleflex LLC | $16.55 | 2025 | Guideliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bidhya Timilsina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.